OPHLF (OPHLF) Stock Price & Analysis
OPHLF (OPHLF) rose 0.00% to USD 14.55 as of June 10, 2026 at 00:53 UTC, according to Nexqual real-time market data.
OPHLF last closed at USD 14.55; the session ranged USD 14.55–14.55 on volume of 120 shares. Market capitalization is $6.84B, with a 52-week range of USD 9.33–18.67 (PNK). Source: Nexqual, June 10, 2026 at 00:53 UTC.
Key Statistics (as of June 10, 2026 at 00:53 UTC)
| Price | USD 14.55 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 14.55 |
| Open | USD 14.55 |
| Day Range | USD 14.55 – 14.55 |
| 52-Week Range | USD 9.33 – 18.67 |
| Volume | 120 shares |
| Market Cap | $6.84B |
| Exchange | PNK |
Technical Analysis (OPHLF)
Nexqual's technical model rates OPHLF "SELL" based on 2 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 00:53 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 14.54) |
| MACD | -0 (negative) |
Analyst Ratings (OPHLF)
Wall Street analysts rate OPHLF "None", per Nexqual as of June 10, 2026 at 00:53 UTC.
| Consensus Rating | None |
|---|
Earnings (OPHLF)
| Next Earnings Date | 2026-07-31 |
|---|---|
| Revenue Estimate | $108.81B |
Source: Nexqual, June 10, 2026 at 00:53 UTC.
Financials & Fundamentals (OPHLF)
| Total Revenue | $515.78B |
|---|---|
| Revenue Growth (YoY) | +5.70% |
| Gross Margin | +72.52% |
| Operating Margin | +3.32% |
| Profit Margin | +13.53% |
| ROE | +8.50% |
| Debt / Equity | 14.12 |
| Current Ratio | 2.86 |
| Total Cash | $237.11B |
| Total Debt | $120.93B |
| Free Cash Flow | $64.83B |
Source: Nexqual, June 10, 2026 at 00:53 UTC.
Financial Health Score (OPHLF)
Nexqual rates OPHLF's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 00:53 UTC.
| Growth | Solid — Revenue +6% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 73%, operating 3% |
| Balance Sheet | Strong — $237.1B cash vs $120.9B debt, net cash position |
| Cash Flow | Solid — FCF $64.8B, 13% margin |
| Efficiency | Mixed — ROE 9%, ROA 5.3% |
Ownership (OPHLF)
| Insider Ownership | +13.24% |
|---|---|
| Institutional Ownership | +42.18% |
| Shares Outstanding | 469.91M |
| Float | 453.49M |
Source: Nexqual, June 10, 2026 at 00:53 UTC.
Leadership (OPHLF)
OPHLF is led by Gyo Sagara (age 67), CEO & Chairman of the Board, per Nexqual as of June 10, 2026 at 00:53 UTC.
| CEO & Chairman of the Board | Gyo Sagara (age 67) |
|---|---|
| President, COO & Representative Director | Toichi Takino (age 57) |
| Corporate Executive Officer and Div. Director of Corporate Strategy, Planning & Bus. Management Div. | Masaki Ito |
| Corporate Officer, Senior Vice President, Discovery & Research | Hiromu Habashita |
| Senior Director of EHS Promotion & Corporate Officer | Satoshi Takahagi |
Major Backers & Investors (OPHLF)
Notable institutional backers of OPHLF include Charles Schwab, Goldman Sachs, WisdomTree Trust-WisdomTree Japan Hedged Equity Fund, according to Nexqual as of June 10, 2026 at 00:53 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Charles Schwab | 1.13% |
| Goldman Sachs | 0.41% |
| WisdomTree Trust-WisdomTree Japan Hedged Equity Fund | 0.21% |
| DEUTSCHE DWS INTERNATIONAL FUND, INC.-DWS CROCI International Fund | 0.2% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.89% |
| BlackRock | 1.14% |
| Dimensional Fund Advisors | 0.3% |
Source: Nexqual, June 10, 2026 at 00:53 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OPHLY | Ono Pharmaceutical Co., Ltd. | USD 4.56 | ▲ 0.22% |
| SGIOF | Shionogi & Co. Ltd. | USD 17.68 | ▲ 10.5% |
| CHGCY | Chugai Pharmaceutical Co., Ltd. | USD 22.85 | ▼ 0.91% |
| DSKYF | Daiichi Sankyo Co., Ltd. | USD 14.96 | ▼ 2.09% |
| SGIOY | Shionogi & Co. Ltd. | USD 8.56 | ▼ 2.28% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:53 UTC. This page is informational and not investment advice.